Search
Search
ASRS: 2025
Roger A. Goldberg, MD, MBA
Show Description +
Dr. Goldberg explores early versus delayed treatment with pegcetacoplan in patients with geographic atrophy in the GALE study out to 4 years.
Posted: 8/06/2025
Roger A. Goldberg, MD, MBA
Dr. Goldberg explores early versus delayed treatment with pegcetacoplan in patients with geographic atrophy in the GALE study out to 4 years.
Posted: 8/06/2025
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2025.
Please log in to leave a comment.